Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status

Fig. 4

Metabolomics pathway network map of significantly altered metabolites in prostate cancer compared to benign prostate and additionally high Gleason score compared to low Gleason score. Metabolites significantly increased in PC are marked on red, significantly decreased in PC are marked on blue. Metabolites significantly increased and decreased in Gleason score ≥ 7 compared to Gleason score = 6 are represented by red and blue arrows, respectively

Back to article page